Benzinga | Nov 4, 2021 08:35AM EDT

BridgeBio Pharma Q3 EPS $(1.06) Down From $(0.98) YoY, Sales $2.34M Down From $8.13M YoY

BridgeBio Pharma (NASDAQ:BBIO) reported quarterly losses of $(1.06) per share. This is a 8.16 percent decrease over losses of $(0.98) per share from the same period last year. The company reported $2.34 million in sales this quarter. This is a 71.16 percent decrease over sales of $8.13 million the same period last year.